Oncotype DX Not Cost - Effective for Low - Risk Breast Cancer

Incremental cost - effectiveness ratio varies across clinical risk groups, sensitive to patient age
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news